{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

19th Oncology Update: Advances and Controversies


LIVE
19th Oncology Update: Advances and Controversies Banner

  • Overview
  • Faculty
  • Brochure
  • Hotel
  • Grant Supporters
  • Exhibitors
  • Sponsors
Add to Calendar 19th Oncology Update: Advances and Controversies 1/13/2023 7:10:00 AM 1/16/2023 7:30:00 PM America/Denver For More Details: https://mdanderson.cloud-cme.com/AdvancesAndControversies2023 Description: The treatment of solid tumors continues to evolve and clinicians must stay abreast of the current information and recent therapeutic advances. Many tumor types require multidisciplinary treatment; many therapies previously studied only in advanced and metastatic settings are now applied in early curative stages as well. Healthcare professionals who care for cancer patients in different stages of dise... Steamboat Grand Hotel false MM/DD/YYYY


Date & Location
Friday, January 13, 2023, 7:10 AM - Monday, January 16, 2023, 7:30 PM, Steamboat Grand Hotel, Steamboat Springs, CO

Target Audience
Specialties - Pathology, Radiation Oncology
Professions - Physician (MD or DO)

Credits
AMA PRA Category 1 Credits™ (30.00 hours), Medical Ethics/Professional Responsibility (1.25 hours), Non-Physician Attendance (30.00 hours)

Overview
The treatment of solid tumors continues to evolve and clinicians must stay abreast of the current information and recent therapeutic advances. Many tumor types require multidisciplinary treatment; many therapies previously studied only in advanced and metastatic settings are now applied in early curative stages as well. Healthcare professionals who care for cancer patients in different stages of disease need to understand the basis for these therapies. Additionally, HCPs must apply the preclinical and clinical data supporting the development and integration of these new therapies into their clinical practice. This educational conference will interactively address current management controversies, updates, and novel therapies for multiple tumor types. It will bring together experts from multiple disciplines involved in the treatment of various solid tumors. The expected outcome is further integration of new cancer care developments into the clinical practice of surgeons, medical oncologists, radiation oncologists, and allied healthcare professionals who care for cancer patients.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Utilize an appropriate sequence for surgical, radiation and chemotherapeutic intervention into the treatment of head & neck cancer, gastrointestinal malignancies, melanoma, lung cancer, breast cancer, gynecologic cancer, and genitourinary cancers.
  2. Describe and apply an optimal treatment approach when given patient scenarios representing a range of disease stages, clinical presentations and comorbidities.
  3. Incorporate preventive, screening and symptom control modalities in oncology care.
  4. Identify patients who will appropriately benefit from novel therapies in the treatment of solid tumors.
  5. Utilize the different surgical, radiation, and systemic treatments including immunotherapies and molecular-targeted therapies for cancers at varying stages of disease.

Registration

Registration on-site is available.

On-site registration for the 19th Annual Oncology Update: Advances and Controversies, will open at 6:30 am on Friday, January 13, 2023, and the conference will begin at 7:00 am.  The conference will adjourn at 8:15 pm on Monday, January 16, 2023.  Advanced registration is encouraged as space and materials are limited.  Please see registration form for applicable fees.

Advanced registration is encouraged. The deadline for advanced registration is January 3, 2023.

Fees:

REGISTRATION CATEGORY

BEFORE
Jan. 3

AFTER
Jan 3

 Physicians/Scientists (MD, PhD)  $600  $650
 MD Anderson Faculty  $375  $400
 Fellows, PAs, Nurses, Social Workers, etc.  $275  $300
 Guest Rate  $150  $150



We accept the following forms of payment:
  •Credit Cards (MasterCard, VISA, and American Express)
  •Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on your profile during the process. 

Telephone registrations are not accepted.

Refund/Cancellation Policy
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before January 3, 2023.  No refunds will be granted after this date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Special Assistance
For additional information or Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]

 
Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status.  Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the course.


Accreditation
Accreditation/Credit Designation - Physicians
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 31.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 


The registration form for this activity is currently unavailable.

ACCOMMODATION

THE STEAMBOAT GRAND HOTEL IS SOLD OUT - Area hotel recommendations are listed below.

A block of rooms has been reserved for conference attendees at the Steamboat Grand Hotel, 2300 Mt. Werner Circle, Steamboat Springs, CO 80487 – 877-269-2628.

Early hotel reservation is suggested.

The hotel phone number is 877-269-2628.

When you make reservations, be sure to mention the MD Anderson Cancer Center 2023 to be assured of receiving the special meeting rate.

Reservations and deposits received after December 12, 2022, will be confirmed if space is available and at currently published hotel guest room rates

Reservations Link:

 https://group.steamboatgrand.com/v2/lodging-offers/promo-code?package=67360&code=MDAN23


Rooms are guaranteed 30 days prior to arrival by taking a full deposit of the entire stay. Upon the taking of the deposit all reservations are unchangeable.  If cancelled the deposit is non-refundable.

Ski Rentals/Lift Ticket Discounts:

Be sure to secure your tickets by calling central reservations: 877-269-2628.

 

Click on each property below for more information:

Ptarmigan Inn / Gravity Haus

Sheraton

West Condos

For more options, use the Steamboat.com link below to browse local lodging by neighborhood. The Steamboat Grand is in the "Base Area" neighborhood, so selecting the BASE AREA as the location will show the closest properties to The Grand!

Steamboat.com



The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Mitigation of Relevant Financial Relationships


The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Eric Gagneaux
Continuing Education Planner
MD Anderson Cancer Center
Activity Administrator
Nothing to disclose
Kimberson C. Tanco, MD
Associate Professor, Palliative Care Med
MD Anderson Cancer Center
CE Reviewer
Grant or research support-Pharmacann
Brian K. Bednarski, MD
Associate Professor
MD Anderson Cancer Center
Co-Director, Faculty
Nothing to disclose
Merrick I. Ross, MD, FACS
Professor of Surgery
UT MD Anderson Cancer Center
Course Director, Faculty
Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Honoraria-Merck Sharp & Dohme Corp. (any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck Sharp & Dohme Corp. (any division)|Honoraria-Amgen Inc.
Sanjiv Agarwala, MD
Professor
Temple University
Faculty
Nothing to disclose
Thomas Aloia, MD, MPH
SVP, CMO
Ascension Health
Faculty
Nothing to disclose
Robert H.I. Andtbacka, MD, FACS, FRCSC
Seven and Eight Biopharmaceuticals Inc.
Faculty
Employment-Seven and Eight Biopharmaceuticals Inc.
Ana M. Aparicio, MD
Associate Professor
MD Anderson Cancer Center
Faculty
Honoraria-Amgen Inc. (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Grant or research support-Sanofi US (Relationship has ended)|Honoraria-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Honoraria-Daiichi Sankyo, Inc. (Relationship has ended)|Honoraria-Janssen Biotech, Inc. (Relationship has ended)|Honoraria-AstraZeneca US (Relationship has ended)
Autumn Atkinson, MD
UTHealth
Faculty
Nothing to disclose
Brian D. Badgwell, MD
Professor of Surgery
MD Anderson Cancer Center
Faculty
Nothing to disclose
Karl Y Bilimoria, MD
Chair
Indiana University
Faculty
Nothing to disclose
Thomas A Buchholz, MD
Scripps MD Anderson Cancer Center
Faculty
Nothing to disclose
Matthew T. Campbell, MD
Associate Professor
MD Anderson Cancer Center
Faculty
Advisor-Eisai, Inc. (Relationship has ended)|Advisor-EMD Serono Inc. (Relationship has ended)|Advisor-Pfizer Inc. (Relationship has ended)|Advisor-Genentech, Inc. (Relationship has ended)|Advisor-AstraZeneca US (Relationship has ended)|Consulting Fee-Exelixis (Relationship has ended)|Consulting Fee-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Consulting Fee-Seattle Genetics, Inc. (Relationship has ended)|Advisor-AXDev (Relationship has ended)|Grant or research support-Exelixis|Grant or research support-Pfizer Inc.|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Aveo|Grant or research support-AstraZeneca US|Speakers Bureau-Bristol-Myers Squibb Company (Relationship has ended)|Speakers Bureau-Roche (Relationship has ended)|Speakers Bureau-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Speakers Bureau-Society for Immunotherapy of Cancer (Relationship has ended)
Abigail S. Caudle, MD, ABS
MD Anderson Cancer Center
Faculty
Nothing to disclose
Edward I Chang, MD
Associate Professor, Plastic Surgery
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Baxter Healthcare Corporation (Relationship has ended)
Brian F. Chapin, MD
Professor
MD Anderson Cancer Center
Faculty
Consulting Fee-Jazz Pharmaceuticals (Relationship has ended)
Mariana C. Chavez MacGregor, MD, Associate Profesor
Associate Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Pfizer Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc.|Advisor-Genomic Health, Inc. (Relationship has ended)
Lorenzo Cohen, PhD
Professor and Director
MD Anderson Cancer Center
Faculty
Nothing to disclose
Christopher H Crane, MD
Memorial Sloan Kettering Cancer Center
Faculty
Honoraria-Elekta
John W. Davis, MD, FACS
Professor
MD Anderson Cancer Center
Faculty
Advisor-Intuitive Surgical, Inc.|Grant or research support-Janssen Biotech, Inc.
Keith Delman, MD
Dr.
Emory University SOM
Faculty
Nothing to disclose
Jason B. Fleming, MD
Chair, Department of GI Oncology
Moffitt Cancer Center
Faculty
Advisor-BioPath Holdings, Inc. |Membership on Advisory Committees or Review Panels, Board Membership, etc.-PanTher Therapeutic, Inc. |Advisor-Candel Therapeutics, Inc|Independent Contractor (included contracted research)-MyCareGorithm|Advisor-Natera
Steven J. Frank, MD
Professor
MD Anderson Cancer Center
Faculty
Consulting Fee-Boston Scientific Corporation (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-C4 Imaging|Grant or research support-Eli Lilly (Relationship has ended)|Grant or research support-Hitachi Medical Systems America, Inc.
Michael Frumovitz, MD, MPH
Professor and Chief Patient Experience Officer
MD Anderson
Faculty
Consulting Fee-Stryker (any division)|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-AkesoBio|Consulting Fee-Seattle Genetics, Inc. (Relationship has ended)
Jeffrey E. Gershenwald, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Consulting Fee-Regeneron Pharmaceuticals, Inc. (Relationship has ended)
Isabella C. Glitza, MD
Associate Professor
UT MD Anderson Cancer Center
Faculty
Consulting Fee-Novartis Pharmaceuticals Corporation|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Pfizer Inc.|Grant or research support-Merck Sharp & Dohme Corp. (any division)
John V. Heymach, MD
Chair, Thoracic-Head & Neck Med Onc
The University of Texas MD Anderson Cancer Center
Faculty
Advisor-AstraZeneca US (Relationship has ended)|Advisor-EMD Serono Inc. (Relationship has ended)|Advisor-Boehringer Ingelheim (Relationship has ended)|Advisor-Catalyst (Relationship has ended)|Advisor-Genentech, Inc. (Relationship has ended)|Advisor-GlaxoSmithKline (Relationship has ended)|Advisor-Lilly USA, LLC|Advisor-Spectrum Pharmaceuticals, Inc. (Relationship has ended)|Advisor-Sanofi US (Relationship has ended)|Advisor-Takeda (Relationship has ended)|Advisor-Mirati (Relationship has ended)|Advisor-Bristol-Myers Squibb Company (Relationship has ended)|Advisor-BrightPath Biotherapeutics (Relationship has ended)|Consulting Fee-Janssen Biotech, Inc.|Advisor-Nexus Health (Relationship has ended)|Consulting Fee-Pneuma Respiratory, Inc. (Relationship has ended)|Consulting Fee-Kairos Venture Investments (Relationship has ended)|Advisor-Reflexion|Consulting Fee-Chugai Biopharmaceuticals (Relationship has ended)|Grant or research support-AstraZeneca US|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Spectrum Pharmaceuticals, Inc.|Royalties or Patent Beneficiary-Spectrum Pharmaceuticals, Inc.
Wayne L. Hofstetter, MD
Professor
MD Anderson Cancer Center
Faculty
Nothing to disclose
Kelly K. Hunt, MD
Professor
MD Anderson Cancer Center
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Armada Health|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US|Grant or research support-Lilly USA, LLC|Grant or research support-Cairn Surgical|Grant or research support-Lumicell
Rosa F. Hwang, MD, FACS
Professor, Breast Surgical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Intuitive Surgical, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Stellanova Therapeutics
Matthew H. Katz, MD
Professor, Surgical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Albert C Koong, MD
Professor
MD Anderson Cancer Center
Faculty
Other: Stocks-Aravive, Inc.
Bradley C Leibovich, MD, FACS
Mayo Clinic
Faculty
Stocks or stock options, excluding diversified mutual funds-Pathright Medical
Jennifer K. Litton, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Honoraria-UpToDate|Grant or research support-Pfizer Inc. (Relationship has ended)|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Zenith|Grant or research support-AstraZeneca US|Grant or research support-EMD Serono Inc.|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-Genentech, Inc.|Speakers Bureau-Clinical Care Options|Speakers Bureau-Medscape (Relationship has ended)|Speakers Bureau-Physician's Education Resource (Relationship has ended)|Speakers Bureau-Prime Oncology (Relationship has ended)|Speakers Bureau-Medpage
Paul F. Mansfield, MD
Professor of Surgical Oncology
UT MD Anderson Cancer Center
Faculty
Stocks or stock options, excluding diversified mutual funds-Amgen Inc.|Stocks or stock options, excluding diversified mutual funds-Stryker (any division)
Jennifer L. McQuade, MD
Assistant Professor
MD Anderson Cancer Center
Faculty
Honoraria-Merck Sharp & Dohme Corp. (any division)
Funda Meric-Bernstam, MD
Chair, Invest. Cancer Therapeutics
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-AbbVie Inc. (Relationship has ended)|Consulting Fee-AstraZeneca US|Consulting Fee-Biovica (Relationship has ended)|Consulting Fee-Black Diamond (Relationship has ended)|Consulting Fee-Debiopharm (Relationship has ended)|Consulting Fee-eFFECTOR Therapeutics (Relationship has ended)|Consulting Fee-Eisai, Inc. (Relationship has ended)|Consulting Fee-F. Hoffmann La Roche (Relationship has ended)|Consulting Fee-Infinity Pharmaceuticals (Relationship has ended)|Consulting Fee-Karyopharm Therapeutics (Relationship has ended)|Consulting Fee-Lengo Therapeutics (Relationship has ended)|Consulting Fee-LOXO-Oncology (Relationship has ended)|Consulting Fee-OnCusp Therapeutics|Consulting Fee-Seattle Genetics, Inc.|Consulting Fee-Silverback Therapeutics (Relationship has ended)|Consulting Fee-Tallac Therapeutics (Relationship has ended)|Consulting Fee-Tyra Biosciences (Relationship has ended)|Consulting Fee-Xencor (Relationship has ended)|Consulting Fee-Zentalis (Relationship has ended)|Consulting Fee-Zymeworks|Grant or research support-Aileron Therapeutics|Grant or research support-AstraZeneca US|Grant or research support-Bayer HealthCare Pharmaceuticals, Inc.|Grant or research support-Calithera|Grant or research support-CytomX Therapeutics|Grant or research support-Curis|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-Debiopharm|Grant or research support-eFFECTOR Therapeutics|Grant or research support-Genentech, Inc.|Grant or research support-Klus Pharma|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Puma Pharmaceuticals|Grant or research support-Taiho Oncology, Inc.|Consulting Fee-GT Apeiron|Consulting Fee-Menarini|Consulting Fee-Ecor1
Lavinia P Middleton, MD
Professor of Pathology
UT MD Anderson Cancer Center
Faculty
Nothing to disclose
Michael Migden, MD
Professor
UT MD Anderson Cancer Center
Faculty
Advisor-Sanofi Genzyme|Advisor-Regeneron Pharmaceuticals, Inc.|Advisor-Replimune|Advisor-Sun pharmaceuticals
Neema Navai, MD
Associate Prof and Deputy Chair
MD Anderson Cancer Center
Faculty
Royalties or Patent Beneficiary-Allergan, Inc.
An T. Ngo-Huang, DO, FAAPMR
Associate Professor
University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Anaeze Offodile II, MD MPH
Assistant Professor
MD Anderson Cancer Center
Faculty
Nothing to disclose
Oliver Peacock, MD, PhD, FRCS
Assistant Professor
MD Anderson
Faculty
Nothing to disclose
George H. Perkins, MD
Professor and Chief Medical Officer Faculty Practice
The University of Texas M D Anderson Cancer Center
Faculty
Nothing to disclose
David C. Rice, MD
Professor, Thoracic & Cardiovasc Surgery
MD Anderson Cancer Center
Faculty
Consulting Fee-Intuitive Surgical, Inc.|Consulting Fee-FUJIFILM Medical Systems USA, Inc. (all divisions)
Maria C Russell, MD
Dr. Maria Russell
Emory
Faculty
Nothing to disclose
Aysegul Sahin, MD
Professor
UT MD Anderson Cancer Center
Faculty
Nothing to disclose
Kathleen M. Schmeler, MD
Professor, Gynecologic Oncology & Reproductive Medicine
The University of MD Anderson Cancer Center
Faculty
Nothing to disclose
Charles A Staley, MD
Professor of Surgery
Emory University School of Medicine
Faculty
Nothing to disclose
Sumit K. Subudhi, MD
Associate Professor
UT MD Anderson Cancer Center
Faculty
Nothing to disclose
Stephen G. Swisher, MD
Division Head
The University of Texas MD Anderson Cancer Center
Faculty
Honoraria-AstraZeneca US (Relationship has ended)
R Houston Thompson, MD
Mayo Clinic
Faculty
Nothing to disclose
Hop S. Tran Cao, MD, FACS
Associate Professor - Surgical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Ching-Wei D. Tzeng, MD
Associate Professor
University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-PanTher|Honoraria-Johnson & Johnson (any division) (Relationship has ended)
Jeffrey S. Weinberg, MD, FAANS, FACS
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
James Welsh, MD
MDACC
Faculty
Nothing to disclose
Robert A. Wolff, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Rae B Reynolds, PhD
Mgr, Adv Practice Providers
MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Cynthia Scott, BS
Office Manager
UT MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose

Support Acknowledgement
The University of Texas MD Anderson Cancer Center gratefully acknowledges the following company for providing an educational grant in support of this activity:

Bristol Myers Squibb Company


Exhibitors
The conference organizing committee wishes to express appreciation to the following companies:

Gold

Amgen
AstraZeneca
Exelixis, Inc.
Janssen Biotech, Inc.
Merck and Co., Inc.
Pfizer Oncology
Seagen


Silver

Eisai Oncology
Gilead Oncology
Mirati Therapeutics
Regeneron


Bronze

Bayer Oncology
Daiichi Sankyo, Inc.
Exact Sciences
Novocure Inc.
Pfizer Oncology


Exhibitor

Aadi Bioscience, Inc.
Astellas Oncology
BostonGene
Caris Life Sciences
Eli Lilly Oncology
Genmab US, Inc.
ImmunoGen, Inc.
Novartis Oncology


Contact Us:
Kelley Gilpin
The University of Texas MD Anderson Cancer Center
PO Box 301407
CPE - Unit 1781
Houston, TX 77230-1407
Phone: 713-563-0603
Email: [email protected]


W9 Form Exhibit at this Event

Exhibitor Packages

Exhibitor Package - Gold Price: $10000.00
Includes:
  • Recognition as a Gold Exhibitor
  • Recognition as a Welcome Reception Supporter
  • Number of Exhibitor Badges: 5
  • Complimentary meals (available with Exhibitor Badge)
  • Product to be shipped directly to facility by exhibitor at own cost. Call for details.
  • Exhibit Location: Premium Assigned

Deadline for order commitment is 2/28/2023 12:00:00 AM.

Exhibitor Package - Silver Price: $7500.00
Includes:
  • Place promotional materials on a designated literature table
  • Number of Exhibitor Badges: 4
  • Complimentary meals (available with Exhibitor Badge)
  • Product to be shipped directly to facility by exhibitor at own cost. Call for details.
  • Exhibit Location: Premium Assigned

Deadline for order commitment is 12/22/2022 12:00:00 AM.

Exhibitor Package - Bronze Price: $5000.00
Includes:
  • 6ft. Tabletop display and two chairs
  • Number of Exhibitor Badges: 3
  • Complimentary meals (available with Exhibitor Badge)
  • Product to be shipped directly to facility by exhibitor at own cost. Call for details.
  • Exhibit Location: Assigned

Deadline for order commitment is 12/22/2022 12:00:00 AM.

Exhibitor Package - Exhibitor Price: $2500.00
Includes:
  • 6ft. Tabletop display and two chairs
  • Number of Exhibitor Badges: 2
  • Complimentary meals (available with Exhibitor Badge)
  • Product to be shipped directly to facility by exhibitor at own cost. Call for details.
  • Exhibit Location: Assigned

Deadline for order commitment is 12/22/2022 12:00:00 AM.

Exhibitor Package - Additional Exhibit Badge Price: $400.00
Includes:
  • Number of Exhibitor Badges: 1

Deadline for order commitment is 1/6/2023 12:00:00 AM.

Exhibitor Package - Additional Exhibit Badge Price: $400.00
Includes:
  • Number of Exhibitor Badges: 1

Deadline for order commitment is 1/6/2023 12:00:00 AM.

Other Contributions/Donations
The conference organizing committee wishes to express appreciation to the following organizations/persons:

The Khalifa Bin Zayad Al Nahyan Foundation

Ms. Kathleen Fitzsimons Love

Dr. John Cargile


The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2023 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram